Search Results - "Fetten, J"

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma by Kreis, W., Budman, D. R., Fetten, J., Gonzales, A. L., Barile, B., Vinciguerra, V.

“…Background: To apply our preclinical findings of cytotoxic synergy with the combination of estramustine phosphate (EP) and docetaxel as the basis of treatment…”
Get full text

Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors by Arkin, S, Blei, F, Fetten, J, Foulke, R, Gilchrist, G S, Heisel, M A, Key, N, Kisker, C T, Kitchen, C, Shafer, F E, Shah, P C, Strickland, D

“…This open-label, emergency-use study evaluated the efficacy and safety of activated human coagulation factor VIIa (recombinant) (rFVIIa) (NovoSeven; Novo…”
Get more information

A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC) by Lee, N., Tsai, C.J., Riaz, N., Wu, V., Brinkman, T., Zhi, W., Fetten, J., Ho, A., Pfister, D.G., Sherman, E.

Get full text

TERT Promoter Mutations Among Oral Cavity Cancers: A Pattern of Failure Analysis by Yu, Y., Fan, D., Song, X., Chen, L., Kang, J.J., Tsai, C.J., McBride, S., Sherman, E., Fetten, J., Dunn, L., Lee, N., Riaz, N.

Get full text

Split High-Dose Cisplatin: An Alternate High-Dose Cisplatin Administration Schedule for Definitive Chemoradiation in Oropharyngeal Cancer by Kang, J.J., Tchekmedyian, V., Fan, M., Wang, H., Kitpanit, S., Mohamed, N., Rybkin, A., Lee, A., Chen, L., Yu, Y., Riaz, N., McBride, S.M., Tsai, C.J., Ho, A., Dunn, L., Fetten, J., Pfister, D.G., Zhang, Z., Lee, N., Sherman, E.

Get full text

A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes by Fetten, JV, Roy, N, Gilboa, E

“…BALB/3T3 cells infected with a retroviral vector encoding the influenza virus nucleoprotein (NP) gene are efficiently lysed by CTL generated in BALB/c mice…”
Get full text

Last-line Treatment with the Quad Shot Regimen for Previously Irradiated Head and Neck Cancers by Fan, D., Fan, M., Wang, H., Lee, A., Yu, Y., Chen, L., Bernstein, M.B., Tsai, C.J., McBride, S., Riaz, N., Mueller, B.A., Gelblum, D., Fetten, J., Dunn, L., Sherman, E., Lee, N., Kang, J.J.

Get full text

Last-line Local Treatment with the Quad Shot Regimen for Previously Irradiated Head and Neck Cancers by Fan, D., Fan, M., Wang, H., Lee, A., Yu, Y., Chen, L., Tsai, C.J., McBride, S., Riaz, N., Bernstein, M.B., Mueller, B.A., Gelblum, D.Y., Fetten, J., Dunn, L., Michel, L., Pfister, D.G., Ho, A., Boyle, J.O., Cohen, M., Roman, B.R., Cracchiolo, J.R., Morris, L., Ganly, I., Singh, B., Shaha, A., Patel, S., Shah, J., Wong, R.J., Sherman, E., Lee, N., Kang, J.J.

Get full text

Symptomatic improvement associated with combined estramustine and vinblastine chemotherapy for metastatic prostate cancer by ATTIVISSIMO, L. A, FETTEN, J. V, KREIS, W

“…We evaluated the effectiveness of combination chemotherapy using estramustine and velban for metastatic prostate cancer. Patients with progressive metasatatic…”
Get full text

Sulindac-induced immune hemolytic anemia by Angeles, M L, Reid, M E, Yacob, U A, Cash, K L, Fetten, J V

“…Sulindac, a nonsteroidal, anti-inflammatory, indene-derived drug, caused life-threatening immune hemolytic anemia in an individual with back pain. A patient…”
Get more information

Oligoclonality of CD8+ T cells in breast cancer patients by Ito, K, Fetten, J, Khalili, H, Hajdu, S, Busch, E, Pergolizzi, R, Vinciguerra, V, Chang, M D

“…Substantial evidence has suggested that T cells play an important role in antitumor immunity. T cells with cytotoxic activity against tumors have been isolated…”
Get full text

Tumor of the heart diagnosed by magnetic resonance imaging by Pizzarello, Roy A., Goldberg, Steven M., Goldman, Mitchell A., Gottesman, Rita, Fetten, James V., Brown, Neal, Kahn, Ellen I., Stein, Harry L.

“…A case of liposarcoma metastatic to the heart is presented. This is a very rare entity and only three prior case reports could be found. Magnetic resonance…”
Get full text

Acquired factor VIII inhibitors—successful treatment with an oral outpatient regimen by Bayer, Ruthee‐Lu, Lichtman, Stuart M., Allen, Steven L., Budman, Daniel R., Buchbinder, Aby, Fetten, James, Kolitz, Jonathan, Loscalzo, John

“…A rare cause of a spontaneous, life threatening coagulopathy in adults is the development of autoantibodies to factor VIII. We recently had the opportunity to…”
Get full text

Acquired factor VII inhibitors : Successful treatment with an oral outpatient regimen by BAYER, R.-L, LICHTMAN, S. M, ALLEN, S. L, BUDMAN, D. R, BUCHBINDER, A, FETTEN, J, KOLITZ, J, LOSCALZO, J

Get full text

Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors by Kaplan, M H, Susin, M, Pahwa, S G, Fetten, J, Allen, S L, Lichtman, S, Sarngadharan, M G, Gallo, R C

“…Neoplastic disease arose in 29 of 200 patients infected with human T lymphotropic virus type III (HTLV-III) seen at a suburban hospital. Seventeen patients had…”
Get more information

A frameshift mutation at the NH sub(2) terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes by Fetten, J V, Roy, N, Gilboa, E

“…BALB/3T3 cells infected with a retroviral vector encoding the influenza virus nucleoprotein (NP) gene are efficiently lysed by CTL generated in BALB/c mice…”
Get full text

Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection by Kaplan, M H, Hall, W W, Susin, M, Pahwa, S, Salahuddin, S Z, Heilman, C, Fetten, J, Coronesi, M, Farber, B F, Smith, S

“…Two intravenous drug users dually infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type II (HTLV-II) developed an…”
Get more information